Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, acquiring, developing and commercialization of products, and therapies for people with rare diseases
Lumos Pharma Inc (NASDAQ:LUMO) The stock was over $12 last month and closed yesterday at $7.60. We could see a sharp rally out of these extreme oversold conditions. With the EMA50 at $11.25 and the EMA200 at much loftier levels, there is a lot of room for this rebound to go. Plus, this company is also trading well below cash levels, which is a great catalyst for a...
Lumos Pharma Inc (NASDAQ:LUMO) another small name that could see a big rally from current levels due to very oversold conditions. Plus, potential double bottom.